Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 230
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT05376930 | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. | ||
| NCT06606093 | Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients | ||
| NCT02241850 | Genetic Polymorphisms Affecting Effect of High Intensity Training | ||
| NCT01634308 | Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation | ||
| NCT05614752 | Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab | ||
| NCT01397240 | The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients | ||
| NCT02069717 | Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) | ||
| NCT06427083 | Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus | ||
| NCT03487562 | Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects | ||
| NCT07533266 | Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer | ||
| NCT06682000 | Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension | ||
| NCT03574415 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean | ||
| NCT07190391 | Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis | ||
| NCT07619833 | To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus | ||
| NCT01094847 | Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine | ||
| NCT06354127 | DWP450 for Treating Moderate to Severe Glabellar Lines | ||
| NCT03573622 | A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions | ||
| NCT02346045 | Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension | ||
| NCT03184324 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study) | ||
| NCT06437951 | to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection | ||
| NCT02953405 | Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease | ||
| NCT02369302 | Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers | ||
| NCT04926623 | Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2) | ||
| NCT01651858 | Nurigra Chewable Tablet in Healthy Adult Male Volunteers | ||
| NCT07516977 | Noseguard for Prevention of Respiratory Infections in Real-World Use | ||
| NCT06119945 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers | ||
| NCT07558707 | Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice | ||
| NCT07326904 | Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease | ||
| NCT04221399 | Type 2 Diabetes Patients With Renal Impairment | ||
| NCT06782139 | Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity | ||
| NCT05226533 | Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients. | ||
| NCT03753477 | Clinical Trial to Investigate the Efficacy and Safety of DWJ1351 | ||
| NCT05954247 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers | ||
| NCT02332044 | Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers | ||
| NCT04120753 | Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab | ||
| NCT04827472 | Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers | ||
| NCT04784910 | Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer | ||
| NCT01635686 | Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers | ||
| NCT03016494 | Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT05813561 | The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis | ||
| NCT06671392 | A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension | ||
| NCT05083299 | Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate | ||
| NCT05389215 | Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF | ||
| NCT04713176 | Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients | ||
| NCT04161001 | Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 | ||
| NCT02180334 | The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones | ||
| NCT05868967 | A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects | ||
| NCT05149274 | Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects | ||
| NCT05378360 | DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities |
